KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Other Working Capital Changes (2017 - 2025)

Amneal Pharmaceuticals (AMRX) has 9 years of Other Working Capital Changes data on record, last reported at -$1.0 million in Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 10.06% year-over-year to -$1.0 million; the TTM value through Dec 2025 reached $19.2 million, up 1898.23%, while the annual FY2025 figure was $19.2 million, 1898.23% up from the prior year.
  • Other Working Capital Changes reached -$1.0 million in Q4 2025 per AMRX's latest filing, down from $10.2 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $115.3 million in Q2 2022 and bottomed at -$85.4 million in Q3 2022.
  • Average Other Working Capital Changes over 5 years is -$279650.0, with a median of -$806000.0 recorded in 2021.
  • The widest YoY moves for Other Working Capital Changes: up 834.72% in 2022, down 2535.58% in 2022.
  • A 5-year view of Other Working Capital Changes shows it stood at -$5.5 million in 2021, then plummeted by 703.01% to -$44.3 million in 2022, then skyrocketed by 70.62% to -$13.0 million in 2023, then skyrocketed by 91.36% to -$1.1 million in 2024, then grew by 10.06% to -$1.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were -$1.0 million in Q4 2025, $10.2 million in Q3 2025, and $9.5 million in Q2 2025.